RADIOFREQUENCY ABLATION DEVICES MARKET FOR PAIN MANAGEMENT ANALYSIS

The global radiofrequency ablation devices market for pain management for pain management is estimated to be valued at US$ 2,493.4 Million in 2023 and is expected to exhibit a CAGR of 19.4% during the forecast period (2023-2030).

Analysts’ Views on the Global Radiofrequency Ablation Devices Market For Pain Management:

Increasing research and development (R&D) studies proving the effectiveness of existing products in the market are expected to further contribute to the growth of the market. For instance, in the article "Reducing AF Ablation Time with Next-Generation Catheters," published by MDPI Journal, in January 2022, Biosense Webster's Qdot microcatheter was evaluated for contact force detection, temperature-controlled ablation, and 3D electroanatomical image integration. It is shown to be a radiofrequency ablation catheter. It includes advanced high-energy ablation, improved temperature monitoring, optimized irrigation and higher signal resolution, giving physicians a simplified workflow that reduces procedure time.These advantages of radiofrequency ablation equipment are expected to increase its adaptability, thereby driving the market growth.

Figure 1. Global Radiofrequency Ablation Devices Market For Pain Management Share (%), By Product Type, 2023

Global Radiofrequency Ablation Devices Market For Pain Management - Drivers

• Increasing prevalence of cancer: Increasing prevalence of cancer is expected to propel the growth of the global radiofrequency ablation devices market for pain management for pain management over the forecast period. For instance, in February 2022, according to data provided by World Health Organization, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. The most common cancers are breast, lung, colon and rectum, and prostate cancers. Breast cancer (2.26 million cases) was the most common disease in 2020 (based on new cases). Lung cancer (2.21 million cases). Colon and rectum (1.93 million cases). Prostate (1.41 million cases).
• Increasing geriatric population: Increasing geriatric population is expected to drive the global radiofrequency ablation devices market for pain management for pain management growth over the forecast period. For instance, in October 2022, according to data provided by World Health Organization, in 2020, the number of people aged 60 years and older outnumbered children younger than 5 years. Between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. The share of the population aged 60 years and over will increase from 1 million in 2020 to 1.4 million. By 2050, the world’s population of people aged 60 years and older will double (2.1 million). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million.

Figure 2. Global Radiofrequency Ablation Devices Market For Pain Management Share (%), By Region, 2023

Global Radiofrequency Ablation Devices Market For Pain Management - Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global radiofrequency ablation devices market for pain management for pain management over the forecast period. North America is estimated to hold 33.5% of the market share in 2023. The global radiofrequency ablation devices market for pain management for pain management is expected to witness significant growth in the coming years, driven by the high prevalence of cancer in North America region is contributing to the growth of the Global Radiofrequency Ablation Devices Market For Pain Management in North America region. For instance, according to the estimates by American Cancer Society, Inc., about 236,740 new cases of lung cancer was diagnosed in the country in 2022. The same source also stated that 79,000 new cases and 13,920 deaths will be reported in 2022 from kidney cancer. Thus, the high burden of cancer is expected to boost the demand for ablation devices, thereby driving the regional market growth.

Global Radiofrequency Ablation Devices Market For Pain Management – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, the U.A.E., Egypt, and others, are facing problems with the transportation of things from one place to another.

However, the COVID-19 pandemic had a negative impact on the global radiofrequency ablation devices market for pain management for pain management, owing to reduction in the bed and operating room capacity, which further led to considerable delays in urgent and semi-elective surgical interventions. According to an American College of Surgeons (ACSs) 2021 report, the nature of surgery and anesthesia practices changed during the COVID-19 pandemic as the most elective and non-urgent cases were postponed.

Global Radiofrequency Ablation Devices Market For Pain Management Segmentation:

The global radiofrequency ablation devices market for pain management report is segmented into product type, application, end user, and region.

• By product type, the market is segmented into [Equipment, Reusable (Probes, Electrodes), Disposables (Cannulas, Needles, RF- Single Use Probe, RF- Single Use Electrodes)],. Out of which equipment is expected to hold the dominant position in the global radiofrequency ablation devices market for pain management for pain management during the forecast period, and this is attributed to increasing product launches and approvals.
• By application, the market is segmented into cardiology, oncology, gynecology, pain management, and others. out of which, cardiology is expected to dominate the market over the forecast period, and this is attributed to increasing prevalence of cardiovascular diseases.
• By end user, the market is segmented into hospitals, specialty clinics, and ambulatory surgical centers, and others. Out of which, hospitals is expected to dominate the market over the forecast period, and this is attributed to the prompt treatment that can lead to proper recovery.

Among all the segmentation, the product type segment is expected to dominate the market over the forecast period, and this is attributed to increasing product launch by key market players. For instance, in April 2022, Koninklijke Philips N.V., a medical device company announced the launched of KODEX-EPD system which offers enhanced imaging and mapping capabilities for RF ablation, including the new Tissue Engagement Viewer and support for the Medtronic DiamondTemp ablation system. For cryoballoon ablation, KODEX-EPD supports a new saline-based occlusion assessment workflow.

Global Radiofrequency Ablation Devices Market For Pain Management - Cross Sectional Analysis:

Key players in the market are focusing on organic growth strategies, such as product launches, which is expected to boost the demand for the global radiofrequency ablation devices market for pain management for pain management in the Europe region. For instance, in October 2022, Biosense Webster, Inc., a medical device company, announced the European launch of the HELIOSTAR Balloon Ablation Catheter. The HELIOSTAR Balloon Ablation Catheter is indicated for use in catheter-based cardiac electrophysiological mapping (stimulating and recording) of the atria and, when used with a compatible multi-channel RF generator, for cardiac ablation.

Global Radiofrequency Ablation Devices Market For Pain Management: Key Developments

On June 28, 2023, Japan Lifeline Co., Ltd., a medical device company, entered into an exclusive distribution agreement with Haemonetics Japan GK, a healthcare company, for

VASCADE MVPTM, a vascular closure device for femoral veins used after ablation surgery for atrial fibrillation.

On June 27, 2023, NeuroOne Medical Technologies, a company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) for its OneRF Ablation System. This technology uses the already implanted sEEG electrodes to record brain activity and allow for ablation of nervous tissue when connected to a proprietary Radio Frequency (RF) generator

On June 19, 2023, Avanos Medical, Inc., a medical device company, announced it has entered into a definitive agreement to acquire Diros Technology Inc., a leading manufacturer of innovative Radio Frequency (RF) products used to treat chronic pain conditions.

On April 7, 2023, Compal Electronics, a leading electronics company, announced the launch of a new radiofrequency ablation (RFA) system for percutaneous, intraoperative coagulation and ablation of soft tissue, including partial or complete ablation of non-resectable liver lesions and a Bilevel ventilator for chronic obstructive pulmonary disease and respiratory insufficiency caused by central and/or mixed apneas.

Global Radiofrequency Ablation Devices Market For Pain Management: Key Trends

• Increasing inorganic growth strategies such as agreement: Increasing inorganic growth strategies, such as agreement by key market players to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in May 2021, Japan Lifeline Co., Ltd., a medical device company, announced that it has entered into a development and supply agreement with Galaxy Medical, Inc., a medical device company, for a Pulsed Electric Field (PEF) ablation catheter for the U.S. market. Alpha1 is a dedicated catheter for the Centauri PEF System. It is used to perform point-by-point ablation with its catheter-tip electrodes, and it is capable for use in a wide range of cases.

Global Radiofrequency Ablation Devices Market For Pain Management: Restraint

Side effects associated with radiofrequency ablation devices: The factor, such as side effects associated with radiofrequency ablation devices, High cost and disadvantages associated with radiofrequency ablation devices, is expected to hinder the market growth over the forecast period. For instance, according to data provided by American Cancer Society, in April 2020, possible side effects after ablation therapy include abdominal pain, infection in the liver, fever, and abnormal liver tests. Serious complications are uncommon.

Key players are focusing on developing advance products with safety and reduced side effects, which is expected to drive the market growth over the forecast period.

Global Radiofrequency Ablation Devices Market For Pain Management - Key Players

The major players operating in the global radiofrequency ablation devices market for pain management for pain management  include Boston Scientific Corporation, Accuray, Inc., Avanos Medical, Inc., Biosense Webster, Inc., Cosman Medical, Inc., Diros Technology, Inc., Kimberly-Clark Corporation, NeuroTherm, Inc., Stryker, AngioDynamics, Medtronic, Sutter Medizintechnik GmbH, Bramsys, Epimed International, sfm medical devices GmbH, Baylis Medical, AtriCure, Inc., ENDO-FLEX GmbH, and Hologic, Inc.

Global Radiofrequency Ablation Devices Market For Pain Management - Definition

Radiofrequency ablation (RFA) uses thermal energy to accomplish targeted tissue destruction. Catheter ablation is the most common type of heart ablation. It's a minimally invasive procedure. A cardiologist threads a catheter (a thin, flexible tube) through a vein, typically through groin and guides it into heart. There are two methods for performing for for performing cardiac ablation catheter ablation using radiofrequency.